SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-154275
Filing Date
2024-06-04
Accepted
2024-06-04 16:18:02
Documents
15
Period of Report
2024-06-04
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d827973d8k.htm   iXBRL 8-K 41737
2 EX-99.1 d827973dex991.htm EX-99.1 11483
6 GRAPHIC g827973g0604042209637.jpg GRAPHIC 3767
  Complete submission text file 0001193125-24-154275.txt   193291

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA fusn-20240604.xsd EX-101.SCH 2853
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE fusn-20240604_lab.xml EX-101.LAB 18689
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fusn-20240604_pre.xml EX-101.PRE 11694
18 EXTRACTED XBRL INSTANCE DOCUMENT d827973d8k_htm.xml XML 3800
Mailing Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6
Business Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6 289-799-0891
Fusion Pharmaceuticals Inc. (Filer) CIK: 0001805890 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39344 | Film No.: 241018294
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)